Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentOpen to AccrualParticipants Off Study and Primary Analysis CompletedPendingTemporarily Closed (Paused) to Accrual and Study Agents/ProductsWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 118 studies. IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children DAIDS Number 12016 Research Area Complications & Comorbidities Study Status Concluded Locality United States P1115: Very Early Intensive Tx on HIV-Infected Infants DAIDS Number 11954 Research Area Cure Study Status Enrolling Locality US & Non-US P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded Locality United States P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Closed to Follow Up Locality Non-US P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Prevention Study Status Closed to Accrual Locality US & Non-US P1111: Safety, Tolerability and PK of Rilpivirine DAIDS Number 11902 Research Area Antiretroviral Strategies Study Status Withdrawn Locality US & Non-US P1110: Safety and PK of RAL in Neonates DAIDS Number 11891 Research Area Treatment Study Status Concluded Locality US & Non-US P1108: Bedaquiline in HIV-infected and uninfected children and adolescents with MDR-TB DAIDS Number 11884 Research Area Tuberculosis Study Status Enrolling Locality Non-US P1107: Cord Blood Transplantation DAIDS Number 11883 Research Area Cure Study Status Closed to Accrual Locality United States P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants DAIDS Number 11882 Research Area Treatment Study Status Closed to Follow Up Locality Non-US Pagination Previous page Prev Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Page 12 Next page Next
IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children DAIDS Number 12016 Research Area Complications & Comorbidities Study Status Concluded Locality United States
P1115: Very Early Intensive Tx on HIV-Infected Infants DAIDS Number 11954 Research Area Cure Study Status Enrolling Locality US & Non-US
P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded Locality United States
P1113: AERAS-404 TB Vaccine in BCG-Primed Infants DAIDS Number 11911 Research Area Tuberculosis Study Status Closed to Follow Up Locality Non-US
P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Prevention Study Status Closed to Accrual Locality US & Non-US
P1111: Safety, Tolerability and PK of Rilpivirine DAIDS Number 11902 Research Area Antiretroviral Strategies Study Status Withdrawn Locality US & Non-US
P1110: Safety and PK of RAL in Neonates DAIDS Number 11891 Research Area Treatment Study Status Concluded Locality US & Non-US
P1108: Bedaquiline in HIV-infected and uninfected children and adolescents with MDR-TB DAIDS Number 11884 Research Area Tuberculosis Study Status Enrolling Locality Non-US
P1107: Cord Blood Transplantation DAIDS Number 11883 Research Area Cure Study Status Closed to Accrual Locality United States
P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants DAIDS Number 11882 Research Area Treatment Study Status Closed to Follow Up Locality Non-US
